DiscoverACC CardiaCast
ACC CardiaCast
Claim Ownership

ACC CardiaCast

Author: American College of Cardiology

Subscribed: 294Played: 5,261
Share

Description

This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.
126 Episodes
Reverse
This episode is part of ACC's ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Explore key updates from the 2026 Guideline for the Treatment of Dyslipidemia with Drs. Eugenia Gianos and Michael Blaha, including connections to the 2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline. Learn practical strategies for implementing lipid management recommendations and building collaborative Lipid and Cardiometabolic Clinic models into clinical practice. This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment initiative, supported by Merck & Co, and Eli Lilly and Company.
This episode is part of ACC's ongoing effort to advance understanding of inflammation and its role in cardiovascular risk assessment. Drs. Antonio Abbate and Brittany Weber discuss the clinical relevance of high-sensitivity C-reactive protein (hs-CRP), including what it measures, which patients should be considered for testing, and how results can help refine cardiovascular risk discussions beyond traditional risk factors. Through a practical, case-based conversation, they explore how hs-CRP can be incorporated into screening, prevention, and management strategies for patients with or at risk for cardiovascular disease. This podcast is part of the ACC's hs-CRP educational initiative, supported by Novo Nordisk. The program provides educational resources to help clinicians interpret inflammatory risk and apply hs-CRP findings to cardiovascular risk assessment, screening, and management decisions. Click here to learn more: https://learn.acc.org/Page/learnHSCRP   
This episode is part of ACC's ongoing initiative on Implementing the 2026 Dyslipidemia Guidelines. Join Drs. Pam Morris and Roger Blumenthal as they explore updates to the Dyslipidemia Guidelines, the patient populations who benefit most, and how to make sense of all of this new information. They provide a practical, evidence‑based discussion designed to support better decision‑making in everyday care.  This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment online course, supported by Merck & Co. and Eli Lilly and Company. Visit the online course to access additional educational activities on this topic.
This episode is part of ACC's ongoing initiative to review aortic stenosis care and its approach to screening and diagnosis. Drs. Wayne Batchelor and Sammy Elmariah review the barriers to aortic stenosis diagnosis. The conversation highlights symptom variability, sex-based and demographic differences, and screening gaps in the real-world practice.    This podcast is part of the ACC's Transforming Aortic Stenosis Care: An Optimal Approach to Screening & Diagnosis initiative, supported by an educational grant from Edwards Lifesciences.  
This episode is part of ACC's ongoing initiative on implementing the 2026 Dyslipidemia guidelines. Join Drs. Samuel Kim and Romit Bhattacharya as they review new therapeutic developments from the guidelines during this discussion on the intersections of dyslipidemia and cardiometabolic syndrome management.   This podcast is part of the ACC's Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment initiative, supported by Merck & Co, and Eli Lilly and Company. 
loading
Comments